2021/05/10 ALA-1000 Receive notice of patent allowance from Innovation, Science and Economic Development Canada (ISED), Application No.3,033,046 Post author:alarpharm Post published:8 . 6 . 2021 Post category:Media releases You Might Also Like 2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895). 21 . 4 . 2021 2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022 2021/04/16 ALA-1000 Receive notice of allowance for patent registration from Korean Intellectual Property Office (Application No. 10-2019-7009185). 21 . 4 . 2021 2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022 2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022
2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895). 21 . 4 . 2021
2022/01/13 Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 14 . 1 . 2022
2021/04/16 ALA-1000 Receive notice of allowance for patent registration from Korean Intellectual Property Office (Application No. 10-2019-7009185). 21 . 4 . 2021
2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022
2022/11/21 ALA-1000 received notice of patent allowance from China National Intellectual Property Administration, Application No. 201780055635.3 21 . 11 . 2022
